IL6 and depressive symptom measurement: Beurel et al. [36] highlight differential associations between specific inflammatory biomarkers and depression subtypes, finding that elevated IL‐6 levels predicted chronicity while increased TNF‐α and CRP levels predicted inflammation‐associated treatment‐resistant depression.